Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 3 6

Status

Completed 6

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 6

Conditions

Ovarian Neoplasms 225Uterine Cervical Neoplasms 181Fallopian Tube Neoplasms 93Carcinoma, Ovarian Epithelial 85Endometrial Neoplasms 74Neoplasms 37Uterine Cervical Dysplasia 35Papillomavirus Infections 35Breast Neoplasms 26Peritoneal Neoplasms 25Vulvar Neoplasms 23Condylomata Acuminata 22Vaginal Neoplasms 18Recurrence 16Testicular Neoplasms 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Burkitt Lymphoma 12Brenner Tumor 12Primary Myelofibrosis 11Multiple Myeloma 11Lymphoma, Non-Hodgkin 11Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Follicular 11Lymphoma, B-Cell, Marginal Zone 11Leukemia, Myeloid, Chronic-Phase 11Leukemia, Myeloid, Accelerated Phase 11Leukemia, Lymphocytic, Chronic, B-Cell 11Blast Crisis 11

Interventions

asoprisnil 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Metrorrhagia × Gynecologic × Clear all
NCT00152256 2008-05-29

A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids

Abbott

Phase 3 Completed
239 enrolled
Gynecologic

Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Hemorrhage

NCT00152269 2008-05-29

Treatment of Uterine Fibroids With Asoprisnil(J867)

Abbott

Phase 3 Completed
475 enrolled
Gynecologic

Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Hemorrhage

NCT00156195 2008-05-29

Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids

Abbott

Phase 3 Completed
523 enrolled
Gynecologic

Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Hemorrhage

NCT00156208 2008-05-29

Safety of Treatment of Uterine Fibroids With Asoprisnil

Abbott

Phase 3 Completed
166 enrolled
Gynecologic

Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Hemorrhage

NCT00160381 2008-05-29

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

Abbott

Phase 3 Completed
432 enrolled
Gynecologic

Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Hemorrhage

NCT00156156 2008-05-28

Study of Asoprisnil in the Treatment of Uterine Fibroids.

Abbott

Phase 3 Completed
149 enrolled
Gynecologic

Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡